Literature DB >> 8720720

Topography of the "vitreous structures" (tractus; membranelles) with respect to the layers of embryonal blood vessels.

H Pau.   

Abstract

BACKGROUND: It is believed that the vascular or primary vitreous, with the exception of the later Cloquet's canal, gradually disappears and is substituted by the avascular or secondary vitreous. It is known that it is possible topographically to objectify mats of fibril concentrations (membranelles or tractus) of stronger light reflection inside the adult vitreous. These concentrations open up in the shape of a funnel from the papilla or Cloquet's canal towards the front of the vitreous.
METHODS: This was a light microscopy investigation on human eyes between the embryonal stage of 3.2 cm and the fetal stage of 12.5 cm and eyes 8 months and 2 years old with persistent vessels of the vitreous.
RESULTS: The investigation showed that at the embryonal stage, the vitreous body is threaded from behind by branches (mats) of the hyaloid artery and from in front by vessels (mats) that go over the rim of the optic cup, i.e., the later vitreous base. Vitreous structures, in the form of horsetail-shaped fibril concentrations, could already be observed histologically in the fetal stage with the disappearance of embryonal blood vessels. These structures begin in the vitreous base, go into the vitreous, run parallel to the retina, and then go to the back of the vitreous and towards the lens. The physiological mats of vitreal fibril concentrations (membranelles or tractus) and the pathological branches of the persistent hyaloid artery, topographically correspond to the mats of the obliterated embryonal blood vessels of the vitreous. These mats grow in relation to the bulbous growth.
CONCLUSIONS: In these investigations an attempt has been made to clarify the question of which embryonal blood vessels. which embryonal and fetal lengths, which different physiological tractus of the vitreous body and which different pathological features of the persistent hyaloid artery correspond.

Entities:  

Mesh:

Year:  1996        PMID: 8720720     DOI: 10.1007/BF00462033

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  [Interpretation of the vitreous body limits as modified meningeal tissue].

Authors:  H PAU; O STOCHDORPH
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1957

2.  [Physiology and pathology of the vitreous body].

Authors:  H PAU
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1951

3.  [Postmortem slitlamp study of the vitreous body. I. Preparation and examination technique].

Authors:  G Eisner
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1971

4.  [Postmortem slitlamp study of the vitreous body. II. Pattern of vitreous structures made visible by the slitbeam].

Authors:  G Eisner
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1971

5.  The fine structure of the vitreous base of the human eye and pathogenesis of pars planitis.

Authors:  J Gärtner
Journal:  Am J Ophthalmol       Date:  1971-06       Impact factor: 5.258

6.  [The structures of the vitreous body in relation to embryonal blood vessels and vitreous-cortex-cells].

Authors:  H Pau
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1969

7.  [Regeneration of the vitreous body and its fibrillae].

Authors:  H Pau
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1965-10-25

Review 8.  [Pathology of the vitreous body. Primary aspects and principles].

Authors:  B Daicker
Journal:  Ophthalmologe       Date:  1993-10       Impact factor: 1.059

9.  Cytological studies on the developing vitreous as related to the hyaloid vessel system.

Authors:  E A Balazs; L Z Toth; V Ozanics
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

10.  The vitreus, an intraocular compartment of the leptomeninx. Electron microscopic observations on rat eyes.

Authors:  J Gärtner
Journal:  Doc Ophthalmol       Date:  1986-03-31       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.